Mechanism for the action of bone morphogenetic proteins and regulation of their activity

Spine

Volumn 27, Issue 16 SUPPL., 2002, Pages

  Ebara, Sohei ^a   Nakayama, Kohzo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone morphogenetic proteins; Implantation; Regulation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; CHORDIN; FOLLISTATIN; HELIX LOOP HELIX PROTEIN; NOGGIN; OSTEOGENIC PROTEIN 1; OSTEOGENIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PEBP2ALPHA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; GROWTH FACTOR RECEPTOR; SMAD6 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

CARTILAGE CELL; DRUG ACTIVITY; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; MESENCHYME; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; GENETICS; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; SMAD6 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0037102474     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200208151-00004     Document Type: Review

References (68)

1. Molecular characterization of helix-loop-helix peptides
2. Smad6 as a transcriptional corepressor
3. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
4. Cleavage of the BMP-4 antagonist chordin by zebrafish tolloid
5. Bone morphogenetic protein-3 is a negative regulator of bone density
6. Expression of a single transfected cDNA converts fibroblasts to myoblasts
7. Transcriptional regulation of the mBMP4 gene through E-box in the 5′ flanking promoter region involving USF
8. MADR2 maps to 18q21 encodes a TGF-beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
9. The dorsalizing neural inducing gene follistatin is an antagonist of BMP-4
10. The mouse bone morphogenetic protein-4 gene: Analysis of promoter utilization in fetal rat calvarial osteoblasts regulation by COUP-TFI orphan receptor
11. Structure and function of the b/HLH/Z domain of USF
12. The adenovirus major late transcription factor Usf is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer
13. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
14. The MAD-related protein Smad7 associates with the TGF-beta receptor and functions as an antagonist of TGF-beta signaling
15. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
16. MADR1 a MAD-related protein that functions in BMP2 signaling pathways
17. Smad6 inhibits signaling by the TGF-beta superfamily
18. Smad6 is a Smad1/5-induced Smad inhibitor: Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter
19. HLH proteins, fly neurogenesis, and vertebrate myogenesis
20. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
21. Cloning of a novel type serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor
22. The E-box motif, recognized by tissue specific nuclear factor(s), is important for BMP-4 gene expression in osteogenic cells
23. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms
24. Characterization and cloning of a receptor for Bmp-2 and BMP-4 from NIH 3T3 cells
25. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
26. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase
27. Opposing BMP and EGF signaling pathways converge on the TGF-beta family mediator Smad1
28. Characterization of a bone morphogenetic protein-responsive Smad-binding element
29. Partnership between DPC4 SMAD proteins in TGF-beta signaling pathways
30. Runx2 is a common target of transforming growth factor beta-1 and bone morphogenetic protein-2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12
31. Human type receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs
32. MADR2 is a substrate of the TGF-beta receptor and its phosphorylation is required for nuclear accumulation and signaling
33. Production of a DPP activity gradient in the early Drosophila embryo through the opposing actions of the SOG and TLD proteins
34. Multiple defects perinatal death in mice deficient in follistatin
35. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins
36. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence
37. Identification of Smad7 a TGF-betainducible antagonist of TGF-beta signaling
38. Transient localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing
39. Identification of a human type receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors
40. Silencing of TGF-beta signaling by the pseudoreceptor BAMBI
41. Human BMP sequences can confer normal dorsal-ventral patterning in the Drosophila embryo
42. Dorsoventral patterning in Xenopus Inhibition of ventral signals by direct binding of chordin to BMP-4
43. Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity
44. Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF
45. Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens
46. Cloning characterization of a human type receptor for bone morphogenetic proteins
47. Twisted gastrulation is a conserved extracellular BMP antagonist
48. Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals
49. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region
50. Multiple forms of the human gene-specific transcription factor USF: I. Complete purification and identification of USF from HeLa cell nuclei
51. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling
52. A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo
53. Induction of Smad6 mRNA by bone morphogenetic proteins
54. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors
55. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4
56. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells
57. Daughters against dpp modulates dpp-organizing activity in Drosophila wing development
58. Bone formation by autoinduction
59. Ski represses bone morphogenic protein signaling in Xenopus mammalian cells
60. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1
61. Novel regulators of bone formation: Molecular clones activities
62. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro
63. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects
64. Negative regulation of BMP/Smad signaling by Tob in osteoblasts
65. Colocalization of noggin bone morphogenetic protein-4 during fracture healing
66. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response
67. SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation
68. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4